Nanomedicines Market 2028 By Product, Application, Type, and Geography | The Insight Partners

    Nanomedicines Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, and Vaccines); Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Other Applications); Type (Nanoparticles, Nanoshells, Nanotubes, and Nanodevices), and Geography

    Report Code: TIPRE00004589 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

    MARKET INTRODUCTION


    The application of nanotechnology in the medical field is called nanomedicine. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism. These can pass directly through the cellular membranes and interact with the cellular DNA and proteins, giving better desired results as compared to the traditional form of medicines. These nanomedicines are normally used across applications such as, diagnosis, targeted drug delivery and imaging.

    MARKET DYNAMICS


    The nanomedicines market is anticipated to grow in the forecast period owing to driving factors such as, large amount of R&D happen in this field and the rising number of cases of cancer. The new applications of nanodevices are expected to offer significant growth opportunities in the global nanomedicines market during the forecast period.

    MARKET SCOPE


    The "Global Nanomedicines Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of nanomedicines market with detailed market segmentation by product, application, type, and geography. The global nanomedicines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading nanomedicines market players and offers key trends and opportunities in the market.

    MARKET SEGMENTATION


    The global nanomedicines market is segmented on the basis of product, application and type. Based on product, the market is classified as therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines. On the basis of application, the market is classified as clinical oncology, infectious diseases, clinical cardiology, orthopedics, and other applications. On the basis of type, the market is categorized as nanoparticles, nanoshells, nanotubes and nanodevices.

    REGIONAL FRAMEWORK


    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global nanomedicines market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nanomedicines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

    The report analyzes factors affecting nanomedicines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nanomedicines market in these regions.

    Get more information on this report :

    MARKET PLAYERS


    The reports cover key developments in the nanomedicines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from nanomedicines market are anticipated to lucrative growth opportunities in the future with the rising demand for nanomedicines market in the global market. Below mentioned is the list of few companies engaged in the nanomedicines market.

    The report also includes the profiles of key nanomedicines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
    • AstraZeneca
    • Cristal Therapeutics
    • Ablynx (A Subsidiary Of Sanofi Company)
    • BlueWillow Biologics
    • Pfizer Inc.
    • CYTIMMUNE SCIENCES, INC.
    • NANOBIOTIX
    • Sirnaomics, Inc.
    • Starpharma Holdings Limited
    • Taiwan Liposome Company, Ltd.
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

    Get more information on this report :

    TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Nanomedicines Market - By Product
    1.3.2 Nanomedicines Market - By Application
    1.3.3 Nanomedicines Market - By Type
    1.3.4 Nanomedicines Market - By Region
    1.3.4.1 By Country
    2. KEY TAKEAWAYS
    3. RESEARCH METHODOLOGY
    4. NANOMEDICINES MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PEST ANALYSIS
    4.2.1 North America - Pest Analysis
    4.2.2 Europe - Pest Analysis
    4.2.3 Asia-Pacific - Pest Analysis
    4.2.4 Middle East and Africa - Pest Analysis
    4.2.5 South and Central America - Pest Analysis
    4.3. EXPERT OPINIONS
    5. NANOMEDICINES MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
    6. NANOMEDICINES MARKET - GLOBAL MARKET ANALYSIS
    6.1. NANOMEDICINES - GLOBAL MARKET OVERVIEW
    6.2. NANOMEDICINES - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
    7.1. OVERVIEW
    7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
    7.3. THERAPEUTICS
    7.3.1. Overview
    7.3.2. Therapeutics Market Forecast and Analysis
    7.4. REGENERATIVE MEDICINE
    7.4.1. Overview
    7.4.2. Regenerative Medicine Market Forecast and Analysis
    7.5. IN-VITRO DIAGNOSTICS
    7.5.1. Overview
    7.5.2. In-Vitro Diagnostics Market Forecast and Analysis
    7.6. IN-VIVO DIAGNOSTICS
    7.6.1. Overview
    7.6.2. In-Vivo Diagnostics Market Forecast and Analysis
    7.7. VACCINES
    7.7.1. Overview
    7.7.2. Vaccines Market Forecast and Analysis
    8. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. CLINICAL ONCOLOGY
    8.3.1. Overview
    8.3.2. Clinical Oncology Market Forecast and Analysis
    8.4. INFECTIOUS DISEASES
    8.4.1. Overview
    8.4.2. Infectious Diseases Market Forecast and Analysis
    8.5. CLINICAL CARDIOLOGY
    8.5.1. Overview
    8.5.2. Clinical Cardiology Market Forecast and Analysis
    8.6. ORTHOPEDICS
    8.6.1. Overview
    8.6.2. Orthopedics Market Forecast and Analysis
    8.7. OTHER APPLICATIONS
    8.7.1. Overview
    8.7.2. Other Applications Market Forecast and Analysis
    9. NANOMEDICINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
    9.1. OVERVIEW
    9.2. TYPE MARKET FORECASTS AND ANALYSIS
    9.3. NANOPARTICLES
    9.3.1. Overview
    9.3.2. Nanoparticles Market Forecast and Analysis
    9.3.3. Metal and Metal Oxide Nanoparticles Market
    9.3.3.1. Overview
    9.3.3.2. Metal and Metal Oxide Nanoparticles Market Forecast and Analysis
    9.3.4. Liposomes Market
    9.3.4.1. Overview
    9.3.4.2. Liposomes Market Forecast and Analysis
    9.3.5. Polymers and Polymer Drug Conjugates Market
    9.3.5.1. Overview
    9.3.5.2. Polymers and Polymer Drug Conjugates Market Forecast and Analysis
    9.3.6. Hydrogel Nanoparticles Market
    9.3.6.1. Overview
    9.3.6.2. Hydrogel Nanoparticles Market Forecast and Analysis
    9.3.7. Dendrimers Market
    9.3.7.1. Overview
    9.3.7.2. Dendrimers Market Forecast and Analysis
    9.3.8. Inorganic Nanoparticles Market
    9.3.8.1. Overview
    9.3.8.2. Inorganic Nanoparticles Market Forecast and Analysis
    9.4. NANOSHELLS
    9.4.1. Overview
    9.4.2. Nanoshells Market Forecast and Analysis
    9.5. NANOTUBES
    9.5.1. Overview
    9.5.2. Nanotubes Market Forecast and Analysis
    9.6. NANODEVICES
    9.6.1. Overview
    9.6.2. Nanodevices Market Forecast and Analysis
    10. NANOMEDICINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Nanomedicines Market Overview
    10.1.2 North America Nanomedicines Market Forecasts and Analysis
    10.1.3 North America Nanomedicines Market Forecasts and Analysis - By Product
    10.1.4 North America Nanomedicines Market Forecasts and Analysis - By Application
    10.1.5 North America Nanomedicines Market Forecasts and Analysis - By Type
    10.1.6 North America Nanomedicines Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Nanomedicines Market
    10.1.6.1.1 United States Nanomedicines Market by Product
    10.1.6.1.2 United States Nanomedicines Market by Application
    10.1.6.1.3 United States Nanomedicines Market by Type
    10.1.6.2 Canada Nanomedicines Market
    10.1.6.2.1 Canada Nanomedicines Market by Product
    10.1.6.2.2 Canada Nanomedicines Market by Application
    10.1.6.2.3 Canada Nanomedicines Market by Type
    10.1.6.3 Mexico Nanomedicines Market
    10.1.6.3.1 Mexico Nanomedicines Market by Product
    10.1.6.3.2 Mexico Nanomedicines Market by Application
    10.1.6.3.3 Mexico Nanomedicines Market by Type
    10.2. EUROPE
    10.2.1 Europe Nanomedicines Market Overview
    10.2.2 Europe Nanomedicines Market Forecasts and Analysis
    10.2.3 Europe Nanomedicines Market Forecasts and Analysis - By Product
    10.2.4 Europe Nanomedicines Market Forecasts and Analysis - By Application
    10.2.5 Europe Nanomedicines Market Forecasts and Analysis - By Type
    10.2.6 Europe Nanomedicines Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Nanomedicines Market
    10.2.6.1.1 Germany Nanomedicines Market by Product
    10.2.6.1.2 Germany Nanomedicines Market by Application
    10.2.6.1.3 Germany Nanomedicines Market by Type
    10.2.6.2 France Nanomedicines Market
    10.2.6.2.1 France Nanomedicines Market by Product
    10.2.6.2.2 France Nanomedicines Market by Application
    10.2.6.2.3 France Nanomedicines Market by Type
    10.2.6.3 Italy Nanomedicines Market
    10.2.6.3.1 Italy Nanomedicines Market by Product
    10.2.6.3.2 Italy Nanomedicines Market by Application
    10.2.6.3.3 Italy Nanomedicines Market by Type
    10.2.6.4 Spain Nanomedicines Market
    10.2.6.4.1 Spain Nanomedicines Market by Product
    10.2.6.4.2 Spain Nanomedicines Market by Application
    10.2.6.4.3 Spain Nanomedicines Market by Type
    10.2.6.5 United Kingdom Nanomedicines Market
    10.2.6.5.1 United Kingdom Nanomedicines Market by Product
    10.2.6.5.2 United Kingdom Nanomedicines Market by Application
    10.2.6.5.3 United Kingdom Nanomedicines Market by Type
    10.2.6.6 Rest of Europe Nanomedicines Market
    10.2.6.6.1 Rest of Europe Nanomedicines Market by Product
    10.2.6.6.2 Rest of Europe Nanomedicines Market by Application
    10.2.6.6.3 Rest of Europe Nanomedicines Market by Type
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Nanomedicines Market Overview
    10.3.2 Asia-Pacific Nanomedicines Market Forecasts and Analysis
    10.3.3 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Product
    10.3.4 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Application
    10.3.5 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Type
    10.3.6 Asia-Pacific Nanomedicines Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Nanomedicines Market
    10.3.6.1.1 Australia Nanomedicines Market by Product
    10.3.6.1.2 Australia Nanomedicines Market by Application
    10.3.6.1.3 Australia Nanomedicines Market by Type
    10.3.6.2 China Nanomedicines Market
    10.3.6.2.1 China Nanomedicines Market by Product
    10.3.6.2.2 China Nanomedicines Market by Application
    10.3.6.2.3 China Nanomedicines Market by Type
    10.3.6.3 India Nanomedicines Market
    10.3.6.3.1 India Nanomedicines Market by Product
    10.3.6.3.2 India Nanomedicines Market by Application
    10.3.6.3.3 India Nanomedicines Market by Type
    10.3.6.4 Japan Nanomedicines Market
    10.3.6.4.1 Japan Nanomedicines Market by Product
    10.3.6.4.2 Japan Nanomedicines Market by Application
    10.3.6.4.3 Japan Nanomedicines Market by Type
    10.3.6.5 South Korea Nanomedicines Market
    10.3.6.5.1 South Korea Nanomedicines Market by Product
    10.3.6.5.2 South Korea Nanomedicines Market by Application
    10.3.6.5.3 South Korea Nanomedicines Market by Type
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Nanomedicines Market Overview
    10.4.2 Middle East and Africa Nanomedicines Market Forecasts and Analysis
    10.4.3 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Product
    10.4.4 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Application
    10.4.5 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Type
    10.4.6 Middle East and Africa Nanomedicines Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Nanomedicines Market
    10.4.6.1.1 South Africa Nanomedicines Market by Product
    10.4.6.1.2 South Africa Nanomedicines Market by Application
    10.4.6.1.3 South Africa Nanomedicines Market by Type
    10.4.6.2 Saudi Arabia Nanomedicines Market
    10.4.6.2.1 Saudi Arabia Nanomedicines Market by Product
    10.4.6.2.2 Saudi Arabia Nanomedicines Market by Application
    10.4.6.2.3 Saudi Arabia Nanomedicines Market by Type
    10.4.6.3 U.A.E Nanomedicines Market
    10.4.6.3.1 U.A.E Nanomedicines Market by Product
    10.4.6.3.2 U.A.E Nanomedicines Market by Application
    10.4.6.3.3 U.A.E Nanomedicines Market by Type
    10.4.6.4 Rest of Middle East and Africa Nanomedicines Market
    10.4.6.4.1 Rest of Middle East and Africa Nanomedicines Market by Product
    10.4.6.4.2 Rest of Middle East and Africa Nanomedicines Market by Application
    10.4.6.4.3 Rest of Middle East and Africa Nanomedicines Market by Type
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Nanomedicines Market Overview
    10.5.2 South and Central America Nanomedicines Market Forecasts and Analysis
    10.5.3 South and Central America Nanomedicines Market Forecasts and Analysis - By Product
    10.5.4 South and Central America Nanomedicines Market Forecasts and Analysis - By Application
    10.5.5 South and Central America Nanomedicines Market Forecasts and Analysis - By Type
    10.5.6 South and Central America Nanomedicines Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Nanomedicines Market
    10.5.6.1.1 Brazil Nanomedicines Market by Product
    10.5.6.1.2 Brazil Nanomedicines Market by Application
    10.5.6.1.3 Brazil Nanomedicines Market by Type
    10.5.6.2 Argentina Nanomedicines Market
    10.5.6.2.1 Argentina Nanomedicines Market by Product
    10.5.6.2.2 Argentina Nanomedicines Market by Application
    10.5.6.2.3 Argentina Nanomedicines Market by Type
    10.5.6.3 Rest of South and Central America Nanomedicines Market
    10.5.6.3.1 Rest of South and Central America Nanomedicines Market by Product
    10.5.6.3.2 Rest of South and Central America Nanomedicines Market by Application
    10.5.6.3.3 Rest of South and Central America Nanomedicines Market by Type
    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
    12. NANOMEDICINES MARKET, KEY COMPANY PROFILES
    12.1. ASTRAZENECA
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. CRISTAL THERAPEUTICS
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. ABLYNX (A SUBSISDIARY OF SANOFI COMPANY)
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. 4. BLUEWILLOW BIOLOGICS
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. PFIZER INC.
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. CYTIMMUNE SCIENCES
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. NANOBIOTIX
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. SIRNAOMICS, INC.
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. STARPHARMA HOLDINGS LIMITED
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. TAIWAN LIPOSOME COMPANY, LTD.
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments
    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    1. AstraZeneca
    2. Cristal Therapeutics
    3. Ablynx (A Subsidiary Of Sanofi Company)
    4. BlueWillow Biologics
    5. Pfizer Inc.
    6. CYTIMMUNE SCIENCES, INC.
    7. NANOBIOTIX
    8. Sirnaomics, Inc.
    9. Starpharma Holdings Limited
    10. Taiwan Liposome Company, Ltd.
    TIPRE00004589
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount